Bliss GVS Pharma Ltd
| Particulars | Sep 2026 | Jun 2026 | Mar 2026 |
|---|---|---|---|
| Revenue | 309.65 | 230.35 | 221.20 |
| Operating Expense | 200.69 | 169.72 | 167.39 |
| Net Profit | 73.57 | 38.62 | 32.42 |
| Net Profit Margin | 23.76% | 16.77% | 14.66% |
| Earning Per Share | 6.93 | 3.65 | 3.06 |
| EBIDTA | 97.59 | 57.33 | 53.13 |
| Effective Tax Rate | 12.33% | 15.32% | 20.55% |
Particulars
Sep 2026
Revenue309.65
Operating Expense200.69
Net Profit73.57
Net Profit Margin23.76
Earning Per Share6.93
EBIDTA97.59
Effective Tax Rate12.33
